cor-1
Peptideexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2009 (NCT01043146)
Timeline
Indications
Mechanism of action
- Coagulation factor VIISupplementation
F7 supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109409 ↗
Also known as
- cor-1
- coresevin m
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01391507 | Phase 2 | Oct 1, 2011 | Corimmun GmbH |
| NCT01043146 | Phase 1 | Oct 1, 2009 | ABX-CRO, Corimmun GmbH |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Corimmun GmbH | For profit | 2 | 2 | 2 | 2009 |
| ABX-CRO | For profit | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1